의약품 바이알 시장 : 업계 동향과 세계 예측 - 사용되는 제조 재료 유형별, 멸균 상태별, 주요 지역별

PHARMACEUTICAL VIALS MARKET: OVERVIEW

As per Roots Analysis, the global pharmaceutical vials market valued at USD 11.03 billion in the current year is anticipated to grow at a CAGR of 6% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Fabrication Material Used

• Glass
• Plastic

Sterilization Status

• Pre-sterilized
• Unsterilized

Key Geographies

• North America
• Europe
• Asia- Pacific
• Latin America
• Middle East and North Africa
• Rest of the World

PHARMACEUTICAL VIALS MARKET: GROWTH AND TRENDS

Primary packaging material such as pharmaceutical glass vials play a crucial role in preserving the stability, efficacy and safety of the drug as it is in direct contact with the packaged therapeutic. Additionally, pharmaceutical primary packaging material assists in maintaining the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Moreover, given the high demand for parenteral formulations and rising vaccination campaigns, there is an urgent need for safe and high-quality pharmaceutical vials, for storing and distributing such formulations in large quantities, across the world.

Despite being the most preferred packaging system, traditional vials are often associated with certain challenges, including chances of breakage under extreme conditions, absence of relevant information (serial or batch number) on the package and potential to delaminate. As a result, several pharmaceutical vials manufacturers are exploring novel techniques to overcome the aforementioned challenges associated with conventional pharmaceutical vials in order to create better packaging solutions. In fact, pharmaceutical vial manufacturers are constantly innovating and creating newer and better packaging solutions in order to meet the changing demands of next generation drug products. Examples of some advancements in this domain include the use of pre-sterilized vials, development of numerous coating materials and adoption of smart drug delivery technologies.

PHARMACEUTICAL VIALS MARKET: KEY INSIGHTS

The report delves into the current state of the global pharmaceutical vials market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Presently, more than 240 pharmaceutical vials are available / being developed by close to 95 manufacturers; most of these players are based in the developed such as North America and Europe.
• Majority of the pharmaceutical vials are fabricated using glass and are available in a variety of volumes; screw caps are amongst the preferred type of vial caps used for such containers.

• Owing to the various benefits, glass emerged as the most preferred fabrication material used for pharmaceutical vials; common types of glass used include type I borosilicate glass (65%) and type III soda-lime glass (16%).
• Majority (60%) of the pharmaceutical vials have a capacity to hold less than 50 ml of drug product; however, very few (8%) vials are capable of storing more than 100 ml of therapeutic products.
• More than 60% of the pharmaceutical vials are designed to be used with screw caps; examples of such vials include 1-Clic(R) Vial System, CryoClear(TM) vials, NextGen(TM) V-Vial(R), Pyrofree vials and Sterile CryoSure(R) Vial.
• In pursuit of building a competitive edge, industry stakeholders are actively upgrading their existing capabilities and adding new competencies in order to enhance their respective product portfolios.
• Over the years, industry players have established several deals to further advance the development / enable the improvement of their proprietary pharmaceutical vials.
• The partnership activity in this domain has increased at a CAGR of over 30% in the past few years.
• Both established players and new entrants have forged strategic partnerships in the recent past; acquisitions emerged as the prominent type of partnership model.
• Current industry trends support the growing need for innovative packaging solutions, primarily to accommodate large scale and specialized production / packaging requirements of increasingly complex drug products.
• Close to 40 players claim to provide a wide range of robotic machinery, having different degrees of freedom, offering notable productivity and cost optimization opportunities.
• Pharmaceutical vials have been in high demand during the COVID-19 pandemic to store and package the novel vaccines and experimental therapies in large quantities.

• The estimated market opportunity for pharmaceutical vials is expected to be well distributed across different types of fabrication material, sterilization status and geographical regions.

Example Players in the Pharmaceutical Vials Market

• Chongqing Zhengchuan Pharmaceutical Packaging
• Corning
• DANYANG XIANGHE PHARMACEUTICAL PACKAGING
• DWK Life Sciences
• Gerresheimer
• Ningbo Zhengli Pharmaceutical Packaging
• Nipro
• Origin Pharma Packaging
• Pacific Vial Manufacturing
• SCHOTT
• SGD Pharma
• Shandong Pharmaceutical Glass
• Stevanato Group
• Thermo Fisher Scientific
• Worldwide Glass Resources

PHARMACEUTICAL VIALS MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the pharmaceutical vials market, focusing on key market segments, including [A] type of fabrication material used, [B] sterilization status and [C] key geographies.
• Market Landscape: A comprehensive evaluation of pharmaceutical vials, based on several relevant parameters, such as [A] type of fabrication material used for container, [B] type of fabrication material used for closure, [C] volume of vial, [D] type of vial cap, [D] sterilization status, [E] type of product, [F] compatible drug class and [G] type of formulation stored. Additionally, a comprehensive evaluation of pharmaceutical vial manufacturers based on several relevant parameters, including [A] year of establishment, [B] company size, [C] location of headquarters and [D] key players (in terms of number of products).
• Company Competitiveness Analysis: A comprehensive competitive analysis of pharmaceutical vial manufacturers, examining factors, such as [A] supplier power and [B] key product specifications.
• Company Profiles: In-depth profiles of the players engaged in the development of pharmaceutical vials, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the pharmaceutical vial domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of fabrication material involved, [D] sterilization status, [E] type of partners and [F] regional distribution of the partnerships.
• Upcoming Trends in Pharmaceutical Packaging: An in-depth analysis of key trends that are likely to impact the future adoption of novel primary packaging systems. Further, a Harvey ball analysis, focusing on the relative effect of each trend on the overall pharmaceutical packaging industry.
• Demand Analysis: A detailed analysis of the current and future demand for pharmaceutical vials, based on various parameters, such as [A] type of fabrication material used, [B] sterilization status and [C] regions.
• Case Study: A detailed discussion on the use of robotic machinery in pharmaceutical manufacturing and fill / finish operations, describing the advantages of using automation / automated technologies in such processes.
• Case Study: A detailed discussion on pre-sterilized / RTU pharmaceutical vials that are currently available. Additionally, the section discusses various sterilization techniques used for primary packaging materials and the advantages of RTU container-closure systems.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Pharmaceutical Packaging
  • 3.2.1. Need for Pharmaceutical Packaging
  • 3.2.2. Types of Pharmaceutical Packaging
• 3.3. Pharmaceutical Vials
  • 3.3.1. Types of Fabrication Materials Used for Vials
    • 3.3.1.1. Glass Vials
    • 3.3.1.2. Plastic Vials
  • 3.3.2. Vial Caps
• 3.4. Innovation in Pharmaceutical Vials

4. MARKET LANDSCAPE

• 4.1. Chapter Overview
• 4.2. Pharmaceutical Vials: Overall Market Landscape
  • 4.2.1. Analysis by Type of Fabrication Material Used (Container)
  • 4.2.2. Analysis by Type of Fabrication Material Used (Closure)
  • 4.2.3. Analysis by Volume of Vial
  • 4.2.4. Analysis by Type of Vial Cap
  • 4.2.5. Analysis by Sterilization Status
  • 4.2.6. Analysis by Type of Product
  • 4.2.7. Analysis by Compatible Drug Class
  • 4.2.8. Analysis by Type of Formulation Stored
• 4.3. Pharmaceutical Vials: List of Manufacturers
  • 4.3.1. Analysis by Year of Establishment
  • 4.3.2. Analysis by Company Size
  • 4.3.3. Analysis by Location of Headquarters
  • 4.3.4. Leading Manufacturers: Analysis by Number of Products

5. COMPANY COMPETITIVENESS ANALYSIS

• 5.1. Chapter Overview
• 5.2. Assumptions and Key Parameters
• 5.3. Methodology
• 5.4. Pharmaceutical Vials: Company Competitiveness Analysis
  • 5.4.1. Company Competitiveness: Small Manufacturers
  • 5.4.2. Company Competitiveness: Mid-sized Manufacturers
  • 5.4.3. Company Competitiveness: Large Manufacturers
  • 5.4.4. Company Competitiveness: Very Large Manufacturers

6. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN NORTH AMERICA

• 6.1. Chapter Overview
• 6.2. Corning
  • 6.2.1. Company Overview
  • 6.2.2. Financial Information
  • 6.2.3. Pharmaceutical Vials Portfolio
  • 6.2.4. Recent Developments and Future Outlook
• 6.3. DWK Life Sciences
  • 6.3.1. Company Overview
  • 6.3.2. Pharmaceutical Vials Portfolio
  • 6.3.3. Recent Developments and Future Outlook
• 6.4. Pacific Vial Manufacturing
  • 6.4.1. Company Overview
  • 6.4.2. Pharmaceutical Vials Portfolio
  • 6.4.3. Recent Developments and Future Outlook
• 6.5. Thermo Fischer Scientific
  • 6.5.1. Company Overview
  • 6.5.2. Financial Information
  • 6.5.3. Pharmaceutical Vials Portfolio
  • 6.5.4. Recent Developments and Future Outlook
• 6.6. Worldwide Glass Resources
  • 6.6.1. Company Overview
  • 6.6.2. Pharmaceutical Vials Portfolio
  • 6.6.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN EUROPE

• 7.1. Chapter Overview
• 7.2. Gerresheimer
  • 7.2.1. Company Overview
  • 7.2.2. Financial Information
  • 7.2.3. Pharmaceutical Vials Portfolio
  • 7.2.4. Recent Developments and Future Outlook
• 7.3. Origin Pharma Packaging
  • 7.3.1. Company Overview
  • 7.3.2. Pharmaceutical Vials Portfolio
  • 7.3.3. Recent Developments and Future Outlook
• 7.4. SCHOTT
  • 7.4.1. Company Overview
  • 7.4.2. Financial Information
  • 7.4.3. Pharmaceutical Vials Portfolio
  • 7.4.4. Recent Developments and Future Outlook
• 7.5. SGD Pharma
  • 7.5.1. Company Overview
  • 7.5.2. Financial Information
  • 7.5.3. Pharmaceutical Vials Portfolio
  • 7.5.4. Recent Developments and Future Outlook
• 7.6. Stevanato Group
  • 7.6.1. Company Overview
  • 7.6.2. Pharmaceutical Vials Portfolio
  • 7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN ASIA PACIFIC

• 8.1. Chongqing Zhengchuan Pharmaceutical Packaging
  • 8.1.1. Company Overview
  • 8.1.2. Pharmaceutical Vials Portfolio
  • 8.1.3. Recent Developments and Future Outlook
• 8.2. Danyang Xianghe Pharmaceutical Packaging
  • 8.2.1. Company Overview
  • 8.2.2. Pharmaceutical Vials Portfolio
  • 8.2.3. Recent Developments and Future Outlook
• 8.3. Ningbo Zhengli Pharmaceutical Packaging
  • 8.3.1. Company Overview
  • 8.3.2. Pharmaceutical Vials Portfolio
  • 8.3.3. Recent Developments and Future Outlook
• 8.4. Nipro
  • 8.4.1. Company Overview
  • 8.4.2. Financial Information
  • 8.4.3. Pharmaceutical Vials Portfolio
  • 8.4.4. Recent Developments and Future Outlook
• 8.5. Shandong Pharmaceutical Glass
  • 8.5.1. Company Overview
  • 8.5.2. Pharmaceutical Vials Portfolio
  • 8.5.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS

• 9.1. Chapter Overview
• 9.2. Partnership Models
• 9.3. Pharmaceutical Vials: List of Partnerships and Collaborations
  • 9.3.1. Analysis by Year of Partnership
  • 9.3.2. Analysis by Type of Partnership
  • 9.3.3. Analysis by Year and Type of Partnership
  • 9.3.4. Analysis by Type of Fabrication Material Used
  • 9.3.5. Analysis by Sterilization Status
  • 9.3.6. Analysis by Type of Partner
  • 9.3.7. Most Active Players: Analysis by Number of Partnerships
  • 9.3.8. Analysis by Geography
    • 9.3.8.1. Region-wise Distribution
    • 9.3.8.2. Country-wise Distribution

10. UPCOMING TRENDS IN PHARMACEUTICAL PACKAGING

• 10.1. Chapter Overview
• 10.2. Preference for Self-medication of Drugs, Through the Use of Modern Drug Delivery Devices
• 10.3. Development of Improved Packaging Components and Efforts to Optimize Manufacturing Costs
• 10.4. Availability of Modular Facilities
• 10.5. Growing Demand and Preference for Personalized Therapies
• 10.6. Rise in Provisions for Automating Fill / Finish Operations
• 10.7. Surge in Partnership Activity
• 10.8. Increase in Initiatives Undertaken by Industry Stakeholders in Developing Regions
• 10.9. Concluding Remarks

11. DEMAND ANALYSIS

• 11.1. Chapter Overview
• 11.2. Scope and Methodology
• 11.3. Global Demand for Pharmaceutical Vials, Till 2035
  • 11.3.1. Analysis by Type of Fabrication Material Used
    • 11.3.1.1. Global Demand for Pharmaceutical Glass Vials, Till 2035
    • 11.3.1.2. Global Demand for Pharmaceutical Plastic Vials, Till 2035
  • 11.3.2. Analysis by Sterilization Status
    • 11.3.2.1. Global Demand for Unsterilized Pharmaceutical Vials, Till 2035
    • 11.3.2.2. Global Demand for Pre-sterilized Pharmaceutical Vials, Till 2035
  • 11.3.3. Analysis by Geography
    • 11.3.3.1. Demand for Pharmaceutical Vials in North America, Till 2035
    • 11.3.3.2. Demand for Pharmaceutical Vials in Europe, Till 2035
    • 11.3.3.3. Demand for Pharmaceutical Vials in Asia Pacific, Till 2035
    • 11.3.3.4. Demand for Pharmaceutical Vials in Middle East and North Africa, Till 2035
    • 11.3.3.5. Demand for Pharmaceutical Vials in Latin America, Till 2035
    • 11.3.3.6. Demand for Pharmaceutical Vials in Rest of the World, Till 2035
• 11.4. Concluding Remarks

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

• 12.1. Chapter Overview
• 12.2. Forecast Methodology and Key Assumptions
• 12.3. Global Pharmaceutical Vials Market, Till 2035
  • 12.3.1. Pharmaceutical Vials Market : Distribution by Type of Fabrication Material Used
    • 12.3.1.1. Pharmaceutical Glass Vials Market, Till 2035
    • 12.3.1.2. Pharmaceutical Plastic Vials Market, Till 2035
  • 12.3.2. Pharmaceutical Vials Market : Distribution by Sterilization Status
    • 12.3.2.1. Unsterilized Pharmaceutical Vials Market, Till 2035
    • 12.3.2.2. Pre-sterilized Pharmaceutical Vials Market, Till 2035
  • 12.3.3. Pharmaceutical Vials Market : Distribution by Geography
    • 12.3.3.1. Pharmaceutical Vials Market in North America, Till 2035
    • 12.3.3.2. Pharmaceutical Vials Market in Europe, Till 2035
    • 12.3.3.3. Pharmaceutical Vials Market in Asia Pacific, Till 2035
    • 12.3.3.4. Pharmaceutical Vials Market in Middle East and North Africa, Till 2035
    • 12.3.3.5. Pharmaceutical Vials Market in Latin America, Till 2035
    • 12.3.3.6. Pharmaceutical Vials Market in Rest of the World, Till 2035

13. CASE STUDY: ROBOTS IN PHARMACEUTICAL PACKAGING

• 13.1. Chapter Overview
• 13.2. Role of Robots in the Pharmaceutical Industry
  • 13.2.1. Key Considerations for Selecting a Robotic System
  • 13.2.2. Advantages of Robotic Systems
  • 13.2.3. Disadvantages of Robotic Systems
• 13.3. Companies Providing Robots for Use in the Pharmaceutical Industry
• 13.4. Companies Providing Equipment Integrated with Robotic Systems for Pharmaceutical Packaging
  • 13.4.1. Aseptic Technologies
  • 13.4.2. AST
  • 13.4.3. Bosch Packaging Technology
  • 13.4.4. Dara Pharmaceutical Packaging
  • 13.4.5. Fedegari Group
  • 13.4.6. IMA
  • 13.4.7. Steriline
  • 13.4.8. Vanrx Pharmasystems

14. CASE STUDY: PRE-STERILIZED / READY-TO-USE PHARMACEUTICAL VIALS

• 14.1. Chapter Overview
• 14.2. Pharmaceutical Packaging and Filling
• 14.3. Limitations of Traditional Primary Packaging
• 14.4. Ready-to-Use Primary Packaging
  • 14.4.1. Sterilization of Primary Packaging Material
    • 14.4.1.1. Sterilization Techniques
  • 14.4.2. Advantages of Ready-to-Use Primary Packaging
  • 14.4.3. Cost Saving Opportunities associated with Ready-To-Use Primary Packaging
  • 14.4.4. Current Demand for Ready-To-Use Primary Packaging and Key Enablers
  • 14.4.5. List of Pre-Sterilized / Ready-to-Use Pharmaceutical Vials
• 14.5. Concluding Remarks

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

• 16.1. Chapter Overview
• 16.2. Company A
  • 16.2.1. Company Snapshot
  • 16.2.2. Interview Transcript: Business Development and Technology Director
• 16.3. Company B
  • 16.3.1. Company Snapshot
  • 16.3.2. Interview Transcript: Former Project Manager of Business Development
• 16.4. Company C
  • 16.4.1. Company Snapshot
  • 16.4.2. Interview Transcript: SiO2 Materials Science

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS